Results The survivin IRS, PI and AI of brain glioma were 3.8±3.9, (28.4±19.5)% and (1.0±0.8)% respectively, and all of them were elevated with the increase of pathological grade of brain glioma (P<0.01 for all).
With the increasing of pathological grade, the expression rate of EGFR increased gradually, the positive rates in grade Ⅰ,Ⅱ,Ⅲ and Ⅳ were 11.1%,33.3%,63.6% and 75.0% respectively, and there was a positive correlation between pathological grade and EGFR.
The expression intensities were positively correlated with the pathological grades (rs=0.620, P<0.01); The mean postoperative survival times of HIF-lα (-), (+), (++) and (+++) groups were 46.11±3.54,37.99±3.72, 23.27±2.76 and 16.96±4.32 months respectively.
There were specially significant differences( P =0.002<0.01, P =0.004<0.01)respectively between the positive expression rate of Survivin mRNA in low malignant brain glioma and that in high malignant brain glioma and among those in different pathological grades of glioma.
There was significant correlation between the ratios of NAA/Cr, Cho/Cr and NAA/Cho and the pathological grading of gliomas, and the ratios of NAA/Cr, Cho/Cr reflected pathologic grade of gliomas relatively steadily;
Results In 55 cases of astrogliocytomas, DI was 1.23±0.22, PI 37.91±3.37. As the pathologic grade increased, DI and PI were also gradually increased in low-grade astrocytoma, anaplastic astrocytome and glioblastoma multicforme, there was significant difference among the three groups (P<0.01).
Methods: The expression of cyclin D1 protein in 29 cases of HCC tissues was detected by immunohistochemical ABC method, and the relationship between its positive rate and pathological grades of HCC tissues was analyzed.
The positive rate of Pgp was increased as pathological grades increased.
The apoptosis in primary oral squamous cell carcinomas (OSCCs) without lymph node (LN) metastases and its relation with clinical stages and pathological grades was investigated.
AI was significantly negatively correlated with pathological grades (P>amp;lt;0.05).
No significant difference in the Pin1 expression was found between disease stages (FIGO), pathological grades or pelvic lymph node metastasis status (P>amp;gt;0.05).